Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This cross-sectional study of pathophysiology will bring additional informations on body composition of patients treated by adjuvant hormonal therapy for breast cancer. This is a complementary study of Metaca study (AU882).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Body composition measurement | Other | DXA, impedance |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Body composition measurement | Other | DXA, impedance |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measure of body composition | To obtain additional data to those of Metaca study (AU882) to assess changes in body composition (fat mass, lean body mass in Kg) in women with breast cancer and treated with adjuvant hormonal therapy following chemotherapy | After more than a year of hormonal therapy |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the distribution of abdominal fat by measuring the waist and hip circumference | After more than a year of hormonal therapy | |
| Assessment of anxiety and depression scores measured by Questionnaire HAD | Questionnaire HAD |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Xavier DURANDO, MD, PhD | Centre Jean Perrin | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Jean Perrin | Clermont-Ferrand | 63011 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 30417829 | Result | Ginzac A, Thivat E, Mouret-Reynier MA, Dubray-Longeras P, Van Praagh I, Passildas J, Abrial C, Kwiatkowski F, Boirie Y, Duclos M, Morio B, Gadea E, Durando X. Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments. Clin Breast Cancer. 2018 Oct;18(5):e1093-e1102. doi: 10.1016/j.clbc.2018.06.010. Epub 2018 Jun 18. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| After more than a year of hormonal therapy |
| Evaluation of quality of life measured by Questionnaire (QLQ-C30) | Questionnaire (QLQ-C30) | After more than a year of hormonal therapy |
| Evaluation of the time sitting measured by Questionnaire IPAQ | Questionnaire IPAQ | After more than a year of hormonal therapy |
| Evaluate the change in body composition longitudinally from the data of the study Metaca | Between after 1 and 6 months after chemotherapy and after more than a year of hormonal therapy |
| D017437 |
| Skin and Connective Tissue Diseases |